Age-dependent onset of insulin resistance in insulin-resistant mice

Biological and Pharmaceutical Bulletin

Volumn 38, Issue 12, 2015, Pages 1925-1934

  Ide, Naohito ^a   Arisawa, Kasumi ^a   Ogura, Kanami ^a   Kagawa, Yoshiyuki ^a   Maeda, Toshio ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Age related onset; Insulin receptor; Insulin resistance; Insulin secretion

Indexed keywords

GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; MESSENGER RNA; NATEGLINIDE; ANTIDIABETIC AGENT; CYCLOHEXANE DERIVATIVE; GLUCOSE BLOOD LEVEL; INSULIN RECEPTOR SUBSTRATE; PHENYLALANINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EPIDIDYMIS FAT; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIVER; MALE; MOUSE; NONHUMAN; OBESITY; ONSET AGE; PROTEIN CONTENT; ADIPOSE TISSUE; AGE; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; COMPLICATION; GENETICS; INBRED MOUSE STRAIN; METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; AGE FACTORS; ANIMALS; BLOOD GLUCOSE; CYCLOHEXANES; GLUCOSE; GLUCOSE INTOLERANCE; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; MALE; MICE, INBRED STRAINS; OBESITY; PHENYLALANINE; RECEPTOR, INSULIN; RNA, MESSENGER;

EID: 84948756133     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b15-00602     Document Type: Article

References (40)

1. Ashcroft FM, Rorsman P. Diabetes mellitus and the β cell: the last ten years. Cell, 148, 1160-1171 (2012).
2. Langenberg C, Sharp SJ, Franks PW, Scott RA, Deloukas P, Forouhi NG, Froguel P, Groop LC, Hansen T, Palla L, Pedersen O, Schulze MB, Tormo MJ, Wheeler E, Agnoli C, Arriola L, Barricarte A, Boeing H, Clarke GM, Clavel-Chapelon F, Duell EJ, Fagherazzi G, Kaaks R, Kerrison ND, Key TJ, Khaw KT, Kröger J, Lajous M, Morris AP, Navarro C, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Rolandsson O, Sacerdote C, Sánchez MJ, Slimani N, Spijkerman AMW, Tumino R. van der A DL, van der Schouw YT, Barroso I, McCarthy MI, Riboli E, Wareham NJ. Gene-lifestyle interaction and Type 2 diabetes: The EPIC Inter Act Case-Cohort Study. PLoS Med., 11, e1001647 (2014).
3. Lefterova MI, Lazar MA. New developments in adipogenesis. Trends Endocrinol. Metab., 20, 107-114 (2009).
4. Lafontan M. Adipose tissue and adipocyte dysregulation. Diabetes Metab., 40, 16-28 (2014).
5. Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, Hirota Y, Mori H, Jonsson A, Sato Y, Yamagata K, Hinokio Y, Wang HY, Tanahashi T, Nakamura N, Oka Y, Iwasaki N, Iwamoto Y, Yamada Y, Seino Y, Maegawa H, Kashiwagi A, Takeda J, Maeda E, Shin HD, Cho YM, Park KS, Lee HK, Ng MC, Ma RC, So WY, Chan JC, Lyssenko V, Tuomi T, Nilsson P, Groop L, Kamatani N, Sekine A, Nakamura Y, Yamamoto K, Yoshida T, Tokunaga K, Itakura M, Makino H, Nanjo K, Kadowaki T, Kasuga M. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat. Genet., 40, 1092-1097 (2008).
6. Hara K, Fujita H, Johnson TA, Yamauchi T, Yasuda K, Horikoshi M, Peng C, Hu C, Ma RC, Imamura M, Iwata M, Tsunoda T, Morizono T, Shojima N, So WY, Leung TF, Kwan P, Zhang R, Wang J, Yu W, Maegawa H, Hirose H, Kaku K, Ito C, Watada H, Tanaka Y, Tobe K, Kashiwagi A, Kawamori R, Jia W, Chan JC, Teo YY, Shyong TE, Kamatani N, Kubo M, Maeda S, Kadowaki T, DIAGRAM consortium. Genome-wide association study identifies three novel loci for type 2 diabetes. Hum. Mol. Genet., 23, 239-246 (2014).
7. Nakamura M, Yamada K. Studies on a diabetic (KK) strain of the mouse. Diabetologia, 3, 212-221 (1967).
8. Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J. Exp. Med., 119, 85-90 (1976).
9. Zucker LM. Hereditary obesity in the rat associated with hyperlipemia. Ann. N. Y. Acad. Sci., 131, 447-458 (1965).
10. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes, 41, 1422-1428 (1992).
11. Maeda T, Sakita R, Kaihatsu T, Miwa M. Sustained hyperglycemia and insulin resistance induced by dietary restriction. Biol. Pharm. Bull., 24, 950-953 (2001).
12. Noge I, Kagawa Y, Maeda T. A new diabetic mouse model derived from the ddY strain. Biol. Pharm. Bull., 33, 988-992 (2010).
13. Maeda T, Noge I, Kagawa Y. Infiltration of M1 macrophages into adipose tissue of ddY-H mice preceding spontaneous appearances of insulin resistance. Biol. Pharm. Bull., 36, 825-832 (2013).
14. Satoh H, Ide N, Kagawa Y, Maeda T. Hepatic steatosis with relation to increased expression of peroxisome proliferator-activated receptor-γ in insulin resistant mice. Biol. Pharm. Bull., 36, 616-623 (2013).
15. Karlsson HK, Zierath JR. Insulin signaling and glucose transport in insulin resistant human skeletal muscle. Cell Biochem. Biophys., 48, 103-113 (2007).
16. Virkamäki A, Ueki K, Kahn CR. Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest., 103, 931-943 (1999).
17. White MF. The insulin signalling system and the IRS proteins. Diabetologia, 40 (Suppl. 2), S2-S17 (1997).
18. Taniguchi CM, Ueki K, Kahn R. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Invest., 115, 718-727 (2005).
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419 (1985).
20. Matsumoto F, Bujo H, Kuramochi D, Saito K, Shibasaki M, Takahashi K, Yoshimoto S, Ichinose M, Saito Y. Effect of nutrition on the cell survival and gene expression of transplanted fat tissues in mice. Biochem. Biophys. Res. Commun., 295, 630-635 (2002).
21. Nan Xia J, Qin Zhang D, Du J, Wen J. Regulation effects of TZQ-F on adipocyte differentiation and insulin action. J. Ethnopharmacol., 150, 692-699 (2013).
22. Rozman J, Rathkolb B, Neschen S, Fuchs H, Gailus-Durner V, Klingenspor M, Wolf E, Hrabě de Angelis M. Glucose tolerance tests for systematic screening of glucose homeostasis in mice. Curr. Protoc. Mouse Biol., 5, 65-84 (2015).
23. Watada S, Yu YM, Fischman AJ, Kurihara T, Shen CA, Tompkins RG, Fagan S. Evaluation of intragastric vs. intraperitoneal glucose tolerance tests in the evaluation of insulin resistance in a rodent model of burn injury and glucagon-like polypeptide-1 treatment. J. Burn Care Res., 35, e66-e72 (2014).
24. Hanif W, Kumar S. Nateglinide: a new rapid-acting insulinotropic agent. Expert Opin. Pharmacother., 2, 1027-1031 (2001).
25. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444, 840-846 (2006).
26. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, Kido Y, Hayashi Y, Nakayama KI, White MF, Kasuga M. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat. Med., 11, 175-182 (2005).
27. Henquin JC. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia, 52, 739-751 (2009).
28. Chachin M, Yamada M, Fujita A, Matsuoka T, Matsushita K, Kurachi Y. Nateglinide, a D-phenylalanine derivative lacking either a sulfonylurea or benzamido moiety, specifically inhibits pancreatic beta-cell-type KATP channels. J. Pharmacol. Exp. Ther., 304, 1025-1032 (2003).
29. Backer JM, Myers MG Jr, Shoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, White MF. Phosphatidylinositol 3-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J., 11, 3469-3479 (1992).
30. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J., 15, 6541-6551 (1996).
31. Cushman SW, Wardzala LJ. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane. J. Biol. Chem., 255, 4758-4762 (1980).
32. Bisbis S, Bailbe D, Tormo MA, Picarel-Blanchot F, Derouet M, Simon J, Portha B. Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver. Am. J. Physiol., 265, E807-E813 (1993).
33. Caro JF, Ittoop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F, Jenquin M, Silverman JF, Khazanie PG, Sinha MK. Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. J. Clin. Invest., 78, 249-258 (1986).
34. Sasaki T, Kuroko M, Sekine S, Matsui S, Kikuchi O, Susanti VY, Kobayashi M, Tanaka Y, Yuasa T, Kitamura T. Overexpression of insulin receptor partially improves obese and diabetic phenotypes in db/db mice. Endocr. J., 62, 787-796 (2015).
35. Davidson MB. Effect of growth hormone on carbohydrate and lipid metabolism. Endocr. Rev., 8, 115-131 (1987).
36. Dominici FP, Cifone D, Bartke A, Turyn D. Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. J. Endocrinol., 161, 383-392 (1999).
37. Araki E, Lipes MA, Patti ME, Brüning JC, Haag B 3rd, Johnson RS, Kahn CR. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature, 372, 186-190 (1994).
38. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature, 372, 182-186 (1994).
39. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF. Disruption of IRS-2 causes type 2 diabetes in mice. Nature, 391, 900-904 (1998).
40. Pederson TM, Kramer DL, Rondinone CM. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes, 50, 24-31 (2001).